Institutional Research Archive

Hedge Fund Letters Archive

Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.

Quarter	Letter Date	Fund Name	QTD	YTD	Tickers	Themes	Quick Take

Home Letters Funds Account

Conestoga Mid Cap Composite 2025 Q2 Investor Letter | Buyside Digest

Back to Fund Profile (Conestoga Mid Cap Composite)

Primary Source Intelligence • Q2 2025 Letter Analysis

Conestoga Mid Cap Composite Quarterly Analysis

Buyside Digest is not affiliated with, and does not endorse, Conestoga Mid Cap Composite. This analysis is provided for institutional research purposes only and is not investment advice.

Fund Returns

QTD+4.76%

YTD-7.13%

Annualized+10.78%

Positioning StanceCONSTRUCTIVE

Market CapMid Cap

GeographyUS

Digest Analysis

Quick Take

"Underperforming the 11.97% benchmark return as unprofitable, high-beta stocks led the market rally following tariff policy relief."

Executive Summary

Conestoga's Small Cap Growth Composite returned 4.76% net in 2Q25, underperforming the Russell 2000 Growth Index's 11.97% return. The quarter was marked by extreme volatility driven by tariff policy announcements, with markets initially declining 11% before rallying 25% from April lows. The portfolio's emphasis on profitable, high-quality companies proved challenging during a period when unprofitable stocks rose 13.1% versus 6.8% for profitable peers. Stock selection was negative across seven of nine sectors, with Technology, Industrials, and Health Care facing the largest headwinds. Key detractors included Descartes Systems and Simulations Plus due to tariff concerns, while Construction Partners benefited from robust infrastructure demand. The strategy exited underperforming positions including Neogen Corp and JBT Marel while adding Bright Horizons. Despite near-term headwinds from quality factor underperformance, management remains confident in their conservative growth approach given small caps' attractive valuations relative to large caps and accelerating earnings growth following years of contraction.

Unlock Full Institutional Analysis

Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.

Sign In to Unlock (3 Free Credits)View Pricing Tiers

Institutional Meta Strategy

Meta Strategy Gauges

Algorithmic conviction, macroeconomic posture, and risk appetite signals extracted from this quarterly letter with qualitative explanations.

Signal Matrix

Market Conviction

68%

CautiousHigh

Moderate (68%)

The manager demonstrates solid conviction through specific position sizing discussions, named holdings with detailed rationales, and explicit exits of underperforming positions like Neogen. They maintain their quality-focused approach despite recent underperformance and provide specific thesis explanations for key holdings. However, the diversified 45-50 stock portfolio and acknowledgment of multiple uncertainties prevents a higher score.

Growth Outlook

25%

BearishBullish

Bearish (25%)

The manager expresses cautious optimism about small caps specifically, noting they trade at historically low valuations relative to large caps with revenue and earnings growth accelerating. However, this is tempered by acknowledgment of ongoing uncertainties including tariff policies, overseas conflicts, and Fed hesitancy about growth and inflation outlook.

Risk Appetite

15%

DefensiveAggressive

Defensive (15%)

The portfolio maintains a conservative positioning with emphasis on profitable, high-quality companies and a modest 2.5% cash weighting. While they added some new positions, the overall stance remains cautious and quality-focused rather than aggressively risk-seeking.

Capital Deployment

5%

De-riskingDeploying

De-risking (5%)

The letter describes adding positions on nine occasions and trimming on four occasions, suggesting modest net deployment activity. However, with no specific cash level changes mentioned and the activity appearing to be primarily rotation rather than significant net deployment, the score reflects limited capital deployment.

Forward Guidance

10%

CautiousExpansionary

Cautious (10%)

The manager explicitly states uncertainty could remain a feature of the market in the near-term due to unknown tariff details, evolving conflicts, and Fed hesitancy. While they express comfort with their portfolio characteristics, the forward guidance is notably cautious about deployment timing.

Language Signal

20%

BearishBullish

Bearish (20%)

Language includes positive terms like 'very comfortable,' 'attractive valuations,' and 'accelerating growth,' but is balanced with risk-focused language including 'uncertainty,' 'headwinds,' 'challenges,' and multiple references to unknown policy outcomes and market volatility.

Perceived Risk

72%

Low RiskElevated

Elevated Risk (72%)

The manager identifies multiple specific macro risks including unknown tariff policy details, evolving overseas conflicts, Fed uncertainty about growth and inflation, and acknowledges that uncertainty could remain a market feature. They also note historical headwinds from narrow leadership and quality underperformance, demonstrating high awareness of environmental risks.

Opportunity Density

65%

ScarceAbundant

Abundant (65%)

The manager sees selective opportunities, particularly in small caps which they describe as trading at historically low valuations relative to large caps with accelerating earnings growth. They added multiple new positions during the quarter, suggesting a reasonable opportunity set, though they emphasize selectivity and quality requirements.

Time Horizon

70%

Short-TermLong-Term

Decade+ (70%)

The strategy demonstrates a multi-year investment horizon with references to long-term holdings (Neogen held since 2007, BFAM described as long-time holding) and focus on long-term growth expectations. The emphasis on fundamental quality characteristics and willingness to hold through short-term volatility suggests a patient, medium to long-term approach.